top of page
Executive Spotlights

ZimVie Inc. Makes Strategic Move: Sells Spine Business to H.I.G. Capital for $375M

Westminster, CO, December 18, 2023 (Globe Newswire) -- ZimVie Inc. (Nasdaq: ZIMV), the 2022 spin-off of the dental and spine business units of Zimmer Biomet, made waves today by finalizing a deal to sell its spine business to H.I.G. Capital, a major player in the alternative investment scene.  Vafa Jamali, President and CEO notes that this allows ZimVie to focus on the global dental markets. 


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Comments


Life Science Headlines
bottom of page